Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Feb;65(2):331–338. doi: 10.1111/j.1476-5381.1979.tb07834.x

The relative toxicity of amitriptyline, imipramine, maprotiline and mianserin in rabbits in vivo.

I E Hughes, S Radwan
PMCID: PMC1668613  PMID: 760906

Abstract

1. Conscious or barbiturate-anaesthetized rabbits were slowly infused intravenously with solutions of amitriptyline, imipramine, maprotiline or mianserin, usually until death occurred. 2. Amitriptyline produced death at the lowest dose, imipramine and maprotiline were intermediate while much higher doses of mianserin were required. 3. Convulsions were induced by the antidepressants in all conscious rabbits and the order of potency of the drugs in producing this effect was amitriptyline greater than or equal to imipramine greater than maprotiline greater than mianserin. 4. All four drugs produced a reduction in heart rate and blood pressure in the anaesthetized rabbits and the order of potency in this respect was amitriptyline greater than imipramine greater than maprotiline greater than mianserin. 5. All four drugs produced significant changes in the ECG compared with control rabbits. The P-R interval was lengthened (potency order amitriptyline greater than imipramine greater than or equal to maprotiline greater than mianserin) and the QRS complex was widened (potency order amitriptyline greater than imipramine greater than or equal to maprotiline greater than mianserin). 7. It is concluded that all four drugs show the toxic effects classically associated with tricyclic antidepressants but the relative toxicity amongst these agents varies considerably and is in the order amitriptyline greater than imipramine greater than maprotiline greater than mianserin.

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bigger J. T., Giardina E. G., Perel J. M., Kantor S. J., Glassman A. H. Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med. 1977 Jan 27;296(4):206–208. doi: 10.1056/NEJM197701272960407. [DOI] [PubMed] [Google Scholar]
  2. Borkowski K. R., Finch L. Cardiovascular responses to intraventricular adrenaline in spontaneous hypertensive rats. Eur J Pharmacol. 1978 Feb 1;47(3):281–290. doi: 10.1016/0014-2999(78)90235-2. [DOI] [PubMed] [Google Scholar]
  3. Burrows G. D., Vohra J., Hunt D., Sloman J. G., Scoggins B. A., Davies B. Cardiac effects of different tricyclic antidepressant drugs. Br J Psychiatry. 1976 Oct;129:335–341. doi: 10.1192/bjp.129.4.335. [DOI] [PubMed] [Google Scholar]
  4. Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., Burns B., de Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br J Psychiatry. 1976 Oct;129:342–345. doi: 10.1192/bjp.129.4.342. [DOI] [PubMed] [Google Scholar]
  5. Ghose K., Coppen A., Turner P. Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology (Berl) 1976 Sep 17;49(2):201–204. doi: 10.1007/BF00427291. [DOI] [PubMed] [Google Scholar]
  6. Harper B., Hughes I. E. A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake. Br J Pharmacol. 1977 Apr;59(4):651–660. doi: 10.1111/j.1476-5381.1977.tb07734.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Itil T. M., Polvan N., Hsu W. Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug). Curr Ther Res Clin Exp. 1972 Jul;14(7):395–413. [PubMed] [Google Scholar]
  8. Jefferson J. W. A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom Med. 1975 Mar-Apr;37(2):160–179. doi: 10.1097/00006842-197503000-00006. [DOI] [PubMed] [Google Scholar]
  9. RASMUSSEN E. B., KRISTJANSEN P. ECG changes during amitryptiline treatment. Am J Psychiatry. 1963 Feb;119:781–782. doi: 10.1176/ajp.119.8.781. [DOI] [PubMed] [Google Scholar]
  10. Thorstrand C. Cardiovascular effects of poisoning with tricyclic antidepressants. Acta Med Scand. 1974 Jun;195(6):505–514. doi: 10.1111/j.0954-6820.1974.tb08179.x. [DOI] [PubMed] [Google Scholar]
  11. Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med Scand. 1976;199(5):337–344. doi: 10.1111/j.0954-6820.1976.tb06745.x. [DOI] [PubMed] [Google Scholar]
  12. Vohra J., Burrows G. D., Sloman G. Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs. Aust N Z J Med. 1975 Feb;5(1):7–11. doi: 10.1111/j.1445-5994.1975.tb03247.x. [DOI] [PubMed] [Google Scholar]
  13. Ziegler V. E., Co B. T., Biggs J. T. Plasma nortriptyline levels and ECG findings. Am J Psychiatry. 1977 Apr;134(4):441–443. doi: 10.1176/ajp.134.4.441. [DOI] [PubMed] [Google Scholar]
  14. van Riezen H. Different central effects of the 5-HT antagonists mianserine and cyproheptadine. Arch Int Pharmacodyn Ther. 1972 Aug;198(2):256–269. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES